Bayesian Capital Management, LP Adicet Bio, Inc. Transaction History
Bayesian Capital Management, LP
- $854 Million
- Q2 2024
A detailed history of Bayesian Capital Management, LP transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 24,421 shares of ACET stock, worth $34,922. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,421
Previous 38,421
36.44%
Holding current value
$34,922
Previous $90,000
67.78%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ACET
# of Institutions
96Shares Held
66.3MCall Options Held
4.3KPut Options Held
36.3K-
Orbimed Advisors LLC San Diego, CA11.4MShares$16.4 Million0.33% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$11.8 Million1.21% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$10.8 Million0.14% of portfolio
-
Goldman Sachs Group Inc New York, NY4.28MShares$6.13 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.62MShares$5.18 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $57.2M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...